Some reassuring news for patients taking GLP-1 receptor agonists: Concerns that the drugs may cause retinopathy may be overblown. A new analysis of nearly 160,000 people with diabetes taking four ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback